Javascript must be enabled to continue!
The Regulatory Effect of Mir-181c-5p On the Differentiation Function of Bone Marrow Mesenchymal Stem Cells in Postmenopausal Osteoporotic Mice
View through CrossRef
Background: Osteoporosis (OP) is a metabolic bone disease syndrome for which there is no good treatment. In this study, we
investigated the expression changes of miR-181c-5p in osteoporosis-derived BMMSCs, and the role and molecular mechanism
in the osteogenic-lipogenic differentiation of BMMSCs.
Methods: In this study, an OP mouse model was successfully established using the ovariectomy method, and osteoporotic-derived
BMMSCs (O-BMMSCs) and sham-operated-derived BMMSCs (S-BMMSCs) were isolated and cultured using the whole bone
marrow method. A genetic screen revealed that miR-181c-5p was differentially expressed in O-BMMSCs and S-BMMSCs. The
expression levels of miR-181c-5p in BMMSCs were overexpressed or inhibited by cell transfection, and the regulatory effects of
miR-181c-5p on the proliferation and osteogenic-adipogenic differentiation of BMMSCs were examined using MTT, multi-directional
differentiation induction, alizarin red staining, oil red O staining, qRT-PCR and Western blot. Candidate target genes for miR181c-5p were screened by target gene prediction software and bioinformatics websites, and target gene validation was performed.
Results: The study found that overexpression of miR-181c-5p or inhibition of miR-181c-5p had no significant effect on the
proliferation ability of BMMSCs. Upregulation of miR-181c-5p could reduce the osteogenic ability and enhance the adipogenic
ability of BMMSCs, while downregulation of miR-181c-5p could increase the osteogenic ability and inhibit the adipogenic ability
of BMMSCs. Besides, Foxo1 was confirmed as a direct target gene of miR-181c-5p, and miR-181c-5p negatively regulated Foxo1
expression. Downregulation of miR-181c-5p in O-BMMSCs promoted Foxo1 expression, improved the osteogenic differentiation
of O-BMMSCs, and reduced abnormal lipogenic differentiation of O-BMMSCs and eventually partially restored the normal
differentiation ability of O-BMMSCs.
Conclusion: miR-181c-5p regulated the osteogenic and adipogenic differentiation of BMMSCs by negatively regulating the
expression of target gene Foxo1. The overexpression of miR-181c-5p in the process of osteoporosis leads to the disruption of the
balance of osteogenic and adipogenic differentiation of BMMSCs, and reduces the bone formation ability of stem cells.
Title: The Regulatory Effect of Mir-181c-5p On the Differentiation Function of Bone Marrow Mesenchymal Stem Cells in Postmenopausal Osteoporotic Mice
Description:
Background: Osteoporosis (OP) is a metabolic bone disease syndrome for which there is no good treatment.
In this study, we
investigated the expression changes of miR-181c-5p in osteoporosis-derived BMMSCs, and the role and molecular mechanism
in the osteogenic-lipogenic differentiation of BMMSCs.
Methods: In this study, an OP mouse model was successfully established using the ovariectomy method, and osteoporotic-derived
BMMSCs (O-BMMSCs) and sham-operated-derived BMMSCs (S-BMMSCs) were isolated and cultured using the whole bone
marrow method.
A genetic screen revealed that miR-181c-5p was differentially expressed in O-BMMSCs and S-BMMSCs.
The
expression levels of miR-181c-5p in BMMSCs were overexpressed or inhibited by cell transfection, and the regulatory effects of
miR-181c-5p on the proliferation and osteogenic-adipogenic differentiation of BMMSCs were examined using MTT, multi-directional
differentiation induction, alizarin red staining, oil red O staining, qRT-PCR and Western blot.
Candidate target genes for miR181c-5p were screened by target gene prediction software and bioinformatics websites, and target gene validation was performed.
Results: The study found that overexpression of miR-181c-5p or inhibition of miR-181c-5p had no significant effect on the
proliferation ability of BMMSCs.
Upregulation of miR-181c-5p could reduce the osteogenic ability and enhance the adipogenic
ability of BMMSCs, while downregulation of miR-181c-5p could increase the osteogenic ability and inhibit the adipogenic ability
of BMMSCs.
Besides, Foxo1 was confirmed as a direct target gene of miR-181c-5p, and miR-181c-5p negatively regulated Foxo1
expression.
Downregulation of miR-181c-5p in O-BMMSCs promoted Foxo1 expression, improved the osteogenic differentiation
of O-BMMSCs, and reduced abnormal lipogenic differentiation of O-BMMSCs and eventually partially restored the normal
differentiation ability of O-BMMSCs.
Conclusion: miR-181c-5p regulated the osteogenic and adipogenic differentiation of BMMSCs by negatively regulating the
expression of target gene Foxo1.
The overexpression of miR-181c-5p in the process of osteoporosis leads to the disruption of the
balance of osteogenic and adipogenic differentiation of BMMSCs, and reduces the bone formation ability of stem cells.
Related Results
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Frequency of Common Chromosomal Abnormalities in Patients with Idiopathic Acquired Aplastic Anemia
Objective: To determine the frequency of common chromosomal aberrations in local population idiopathic determine the frequency of common chromosomal aberrations in local population...
In Silico and In Vivo Evaluation of microRNA-181c-5p’s Role in Hepatocellular Carcinoma
In Silico and In Vivo Evaluation of microRNA-181c-5p’s Role in Hepatocellular Carcinoma
Hepatocellular carcinoma (HCC) is a fatal disease, accounting for 75–85% of primary liver cancers. The conclusive research on miR-181c-5p’s role in hepatocarcinogenesis, whether it...
The dynamic regulation of miR-181c-5p in heart failure
The dynamic regulation of miR-181c-5p in heart failure
Cardiac miR-181c-5p expression associates with cardiac damage and heart failure development, but the underlying molecular mechanisms are not fully understood. In this thesis we dug...
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
GW24-e2497 Circulating MicroRNAs as Potential Biomarkers of Coagulation Dysfunction in Patients with Vulnerable Coronary Artery Disease
Objectives
The activation of coagulation and fibrinolysis plays a critical role in the incidence of coronary events. MicroRNAs (miRNAs) are small non-coding ribon...
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Deranged MicroRNA 16-2 Expression Contributes to Erythropoiesis in Polycythemia Vera.
Abstract
Abstract 3896
Poster Board III-832
We previously reported the finding of significantly raised levels of mature microRNA 16 (mi...
Stem cells
Stem cells
What is a stem cell? The term is a combination of ‘cell’ and ‘stem’. A cell is a major category of living thing, while a stem is a site of growth and support for something else. In...
Characterization of Hematopoiesis in Tp53 R172H Mutant Mice
Characterization of Hematopoiesis in Tp53 R172H Mutant Mice
Abstract
In a cohort of 150 patients with myelodysplastic syndrome (MDS), the most common adult myeloid malignancy, missense mutations in TP53 were more common than ...
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Expression of microRNAs, miR‐21, miR‐31, miR‐122, miR‐145, miR‐146a, miR‐200c, miR‐221, miR‐222, and miR‐223 in patients with hepatocellular carcinoma or intrahepatic cholangiocarcinoma and its prognostic significance
Abstract
MicroRNAs are a class of non‐coding molecules found to regulate a variety of cellular functions in health and disease. Dysregulation of microRNAs is invo...

